Business Standard

Drug controller hints vaccine approval will make it a 'happy new year'

V G Somani's statement comes even as subject expert committee is set to meet on Jan 1 to consider three emergency-use authorisation applications

vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
Premium

SII will also soon announce the safety data of Novavax, another indigenously developed vaccine for covid by the company.

BS Reporter New Delhi
India could start the new year with an approved Covid vaccine, the country's drug regulator indicated on Thursday even as the subject expert committee would meet on January 1 to consider three emergency-use authorisation applications including Serum Institute of India, Bharat Biotech and Pfizer-BioNtech. 

“Probably we will have a happy new year with something in hand, that’s what I can hint at,” said V G Somani, Drug Controller General of India speaking at a webinar on the science of vaccine development. 

Somani assured that processes were fast tracked by allowing parallel and seamless phase one and two trials and there

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 31 2020 | 5:31 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com